Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk of being killed by police use of force in the United States by age, race–ethnicity, and sex
2019 Standout
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
The Nuclear Factor NF- B Pathway in Inflammation
2009 Standout
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
2010
Structure and function of matrix metalloproteinases and TIMPs
2006 Standout
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
The Primary Outcome Is Positive — Is That Good Enough?
2016
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
NF-κB signaling in inflammation
2017 Standout
The NLRP3 inflammasome in acute myocardial infarction
2017
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study
2008
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling
2007
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes
2009
Regulation of Matrix Metalloproteinase (Matrixin) Genes in Blood Vessels: A Multi-Step Recruitment Model for Pathological Remodelling
2003
The Myth of the “Vulnerable Plaque”
2015
Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial
2009
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention
2009
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials
2008 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups
2014
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
2017
Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (from the British Columbia Cardiac Registry)
2009
Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes
2011
Transradial cardiac procedures: the state of the art
2010
Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis
2015
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
2018
Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis
2004
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
2015
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
2014
Targeting Interleukin-1 in Heart Failure and Inflammatory Heart Disease
2014
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology
2013
Macrophage heterogeneity in atherosclerotic plaques
2009
Acute Myocardial Infarction
2017
A Test in Context
2016
The Transradial Approach to Percutaneous Coronary Intervention
2010
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
2018
Atherosclerosis
2019 Standout
Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-κB
2005
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
2004
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
2016
Inflammatory processes in cardiovascular disease: a route to targeted therapies
2016
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling
2011
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line
2005 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes
2019
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
2017
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Interleukin-1 blockade in cardiovascular diseases: a clinical update
2018
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction
2015
Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
2013
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Minimizing the Risks of Anticoagulants and Platelet Inhibitors
2010
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
2018
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
From C-Reactive Protein to Interleukin-6 to Interleukin-1
2016
NF-κB Is a Key Mediator of Cerebral Aneurysm Formation
2007
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Abdominal Aortic Aneurysm
2006 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Furin-Like Proprotein Convertases Are Central Regulators of the Membrane Type Matrix Metalloproteinase–Pro-Matrix Metalloproteinase-2 Proteolytic Cascade in Atherosclerosis
2005
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Treatment of Anemia in Patients With Heart Disease
2013
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Acute Coronary Syndromes
2017
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
Works of Alexander Chase being referenced
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)
2008
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
2013
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
2014
Role of Nuclear Factor-κB Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo
2002